Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3328719 | Critical Reviews in Oncology/Hematology | 2014 | 10 Pages |
Abstract
The current management of locally advanced breast cancer (LABC) is based on tri-modality treatment including chemotherapy, radiotherapy and surgery. The concept of preoperative concurrent or sequential chemoradiation for LABC was initially reported more than a decade ago; however this concept did not gain popularity because of the low benefit/risk ratio and the lack of strong data supporting the concept. The purpose of the current systematic review was to explore the published data about preoperative chemoradiation (sequential and/or concurrent) using whole breast irradiation in terms of toxicity and outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Orit Kaidar-Person, Abraham Kuten, Yazid Belkacemi,